Critical Contrast: QHSLab (OTCMKTS:USAQ) & Vivos Therapeutics (NASDAQ:VVOS)

QHSLab (OTCMKTS:USAQ) and Vivos Therapeutics (NASDAQ:VVOS) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership and analyst recommendations.

Profitability

This table compares QHSLab and Vivos Therapeutics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
QHSLab	-3.24%	N/A	-3.43%
Vivos Therapeutics	-86.19%	-335.04%	-93.58%

Volatility & Risk

QHSLab has a beta of 0.78, indicating that its share price is 22% less volatile than the S&P 500. Comparatively, Vivos Therapeutics has a beta of 7.02, indicating that its share price is 602% more volatile than the S&P 500.

Earnings and Valuation

This table compares QHSLab and Vivos Therapeutics”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
QHSLab	$1.41 million	1.59	-$470,000.00	($0.04)	-5.29
Vivos Therapeutics	$14.63 million	0.85	-$13.58 million	($1.73)	-1.22

QHSLab has higher earnings, but lower revenue than Vivos Therapeutics. QHSLab is trading at a lower price-to-earnings ratio than Vivos Therapeutics, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for QHSLab and Vivos Therapeutics, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
QHSLab	0	0	0	0	0.00
Vivos Therapeutics	0	1	1	0	2.50

Vivos Therapeutics has a consensus price target of $4.82, suggesting a potential upside of 128.28%. Given Vivos Therapeutics’ stronger consensus rating and higher probable upside, analysts plainly believe Vivos Therapeutics is more favorable than QHSLab.

Insider & Institutional Ownership

26.4% of Vivos Therapeutics shares are owned by institutional investors. 74.2% of QHSLab shares are owned by insiders. Comparatively, 3.0% of Vivos Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

About QHSLab

QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. The company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. QHSLab, Inc. was incorporated in 1983 and is based in West Palm Beach, Florida.

About Vivos Therapeutics

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.